Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Poliomyelitis

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Bacterial Gastroenteritis

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Reply to 'Assessing the hepatitis C epidemiology in Switzerland: It's not that trivial'.

Journal of viral hepatitis·2023

Same author

Chronic hepatitis C virus infections in Switzerland in 2020: Lower than expected and suggesting achievement of WHO elimination targets.

Journal of viral hepatitis·2023

Same author

Modelling the impact of different testing strategies for HCV infection in Switzerland.

Journal of virus eradication·2019

Same author

Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland.

Swiss medical weekly·2019

Same author

The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988-2015.

Swiss medical weekly·2018

Same author

Public Health Policy and Experience of the 2009 H1N1 Influenza Pandemic in Pune, India.

International journal of health policy and management·2018

Search research articles

Related Experiment Video

Updated: Jun 18, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Vaccines for enteric diseases: update on recent developments.

Christian Schaetti¹

¹Department of Public Health and Epidemiology, Swiss Tropical Institute, Socinstrasse 57, 4002 Basel, Switzerland. christian.schaetti@unibas.ch

Expert Review of Vaccines

|December 1, 2009

Summary

The 5th International Conference on Vaccines for Enteric Diseases (VED) showcased over 100 scientific presentations on enteric disease research and vaccine development. Experts discussed key topics including typhoid, rotavirus, norovirus, and cholera vaccines.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Related Experiment Videos

Last Updated: Jun 18, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Area of Science:

Vaccinology
Infectious Diseases
Microbiology

Background:

The 5th International Conference on Vaccines for Enteric Diseases (VED) convened over 250 international delegates to discuss advancements in enteric disease research and vaccine development.
The conference provided a platform for academic, industry, and donor stakeholders to review progress since the 2007 VED meeting.

Framework:

The event featured 56 oral presentations and 46 posters, covering a wide spectrum of enteric pathogens and vaccine strategies.
Discussions focused on critical areas such as typhoid fever, salmonelloses, rotavirus, norovirus, Shigella infections, and cholera.

Implementation:

Emphasis was placed on mucosal immunization and delivery systems for enhanced vaccine efficacy.
Emerging challenges and research on enterotoxigenic Escherichia coli (ETEC) were also highlighted.

Implications:

The conference facilitated knowledge exchange, fostering collaboration for future enteric disease vaccine development.
Insights gained are crucial for public health initiatives aimed at reducing the burden of enteric infections globally.